ClearPoint Neuro, Inc. (CLPT) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $11.40 (+1.97%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 21, 2025 | Frank Takkinen | Lake Street | $30.00 | +163.2% |
| Aug 27, 2024 | Frank Takkinen | Loop Capital Markets | $15.00 | +31.6% |
| Mar 13, 2024 | Mathew Blackman | Stifel Nicolaus | $9.00 | -21.1% |
Top Analysts Covering CLPT
CLPT vs Sector & Market
| Metric | CLPT | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +57.9% | +1150.2% | +14.9% |
| P/E Ratio | -12.28 | 6.88 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $13M | $13M | $13M | 1 |
| 2026-09-30 | $13M | $14M | $14M | 1 |
| 2026-12-31 | $14M | $14M | $15M | 1 |
| 2027-03-31 | $15M | $15M | $15M | 1 |
| 2027-06-30 | $16M | $16M | $16M | 1 |
| 2027-09-30 | $17M | $17M | $17M | 1 |
| 2027-12-31 | $18M | $18M | $18M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $-0.26 | $-0.26 | $-0.25 | 1 |
| 2026-09-30 | $-0.24 | $-0.24 | $-0.24 | 1 |
| 2026-12-31 | $-0.22 | $-0.21 | $-0.21 | 1 |
| 2027-03-31 | $-0.21 | $-0.21 | $-0.21 | 1 |
| 2027-06-30 | $-0.20 | $-0.20 | $-0.20 | 1 |
| 2027-09-30 | $-0.18 | $-0.18 | $-0.18 | 1 |
| 2027-12-31 | $-0.16 | $-0.16 | $-0.16 | 1 |
Frequently Asked Questions
What is the analyst consensus for CLPT?
The consensus among 2 analysts covering ClearPoint Neuro, Inc. (CLPT) is Buy with an average price target of $18.00.
What is the highest price target for CLPT?
The highest price target for CLPT is $30.00, set by Frank Takkinen at Lake Street on 2025-01-21.
What is the lowest price target for CLPT?
The lowest price target for CLPT is $9.00, set by Mathew Blackman at Stifel Nicolaus on 2024-03-13.
How many analysts cover CLPT?
2 analysts have issued ratings for ClearPoint Neuro, Inc. in the past 12 months.
Is CLPT a buy or sell right now?
Based on 2 analyst ratings, CLPT has a consensus rating of Buy (2.00/5) with a +57.9% upside to the consensus target of $18.00.
What are the earnings estimates for CLPT?
Analysts estimate CLPT will report EPS of $-0.26 for the period ending 2026-06-30, with revenue estimated at $13M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.